Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: addendum: patient should be given a prescription for plavix 75mg qd. the prescription was not written in the original discharge scripts, but the information was relayed to the patient to resume taking plavix 6 days after discharge. plavix was called in to a at on at 1800. medications on admission: 1. aspirin 325 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 2. simvastatin 40 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 3. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 4. donepezil 5 mg tablet sig: two (2) tablet po hs (at bedtime). disp:*30 tablet(s)* refills:*2* 5. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 6. humalog mix 75-25 75-25 unit/ml suspension sig: thirty (30) units subcutaneous qam. disp:*1 vial* refills:*2* 7. nitroglycerin 0.4 mg/spray spray, non-aerosol sig: sprays translingual prn as needed for chest pain. disp:*1 unit* refills:*2* 8. atenolol 50 mg tablet sig: 1 and tablet po once a day. disp:*60 tablet(s)* refills:*2* discharge medications: 1. aspirin 325 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 2. simvastatin 40 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 3. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 4. donepezil 5 mg tablet sig: two (2) tablet po hs (at bedtime). disp:*30 tablet(s)* refills:*2* 5. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 6. humalog mix 75-25 75-25 unit/ml suspension sig: thirty (30) units subcutaneous qam. disp:*1 vial* refills:*2* 7. nitroglycerin 0.4 mg/spray spray, non-aerosol sig: sprays translingual prn as needed for chest pain. disp:*1 unit* refills:*2* 8. atenolol 50 mg tablet sig: 1 and tablet po once a day. disp:*60 tablet(s)* refills:*2* discharge disposition: home with service facility: discharge diagnosis: coronary artery disease (diffuse 3 vessel) non st elevation myocardial infarction choledocholithaisis discharge condition: stable, afebrile, ambulatory, chest pain free, abdominal pain free discharge instructions: -please take all your medications as directed -please follow up with dr. ( cardiology)in weeks -please follow up with your pcp 1 month -if you should have any more chest pain, please take your medications and phone your primary care provider immediately administer your insulin as directed by a physician resume taking medication called plavix on followup instructions: cardiology: dr. , ( in weeks gastroenterology: dr. , (,, only if you have problems call pcp regarding making an appointment md procedure: coronary arteriography using two catheters left heart cardiac catheterization endoscopic removal of stone(s) from biliary tract endoscopic sphincterotomy and papillotomy diagnoses: subendocardial infarction, initial episode of care anemia, unspecified coronary atherosclerosis of native coronary artery pure hypercholesterolemia congestive heart failure, unspecified personal history of tobacco use chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease long-term (current) use of insulin old myocardial infarction cardiac pacemaker in situ alzheimer's disease dementia in conditions classified elsewhere without behavioral disturbance sinoatrial node dysfunction diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled calculus of gallbladder and bile duct without cholecystitis, with obstruction conjunctivitis, unspecified 

Answer: The patient is high likely exposed to